Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-08

Clinical Trial Update: Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing morning versus evening dosing of perindopril for blood pressure control in adults with type 2 diabetes and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • perindopril (perindopril)

Snippet

Sponsor: Yaounde Central Hospital | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 4 | Status: COMPLETED